Venom: Let There Be Carnage Updates: It wasn’t until the fourth weekend of July that Hollywood realized the full scope of 2021’s Not-So-Hot Vaxx Summer of low ticket sales. Jungle Cruise, starring Dwayne Johnson and Emily Blunt as an old-fashioned Disneyland amusement park ride, opened to a “soft” $34.2 million in North American theatres from July 23 to 25 (with another $30 million from concurrent Disney+ premium video rentals) — disappointing numbers for a brassy kids’ film that cost more than $200 million to produce and at least another $100 million to market.
On the surface, it doesn’t seem like a huge deal: a month’s wait during which theatre moviegoing might presumably return to normalcy if vaccination rates continue to increase after reaching their highest level in months.
However, no new footage from the sequel to the 2018 sci-fi symbiote movie Venom (which made an unexpectedly strong $856 million worldwide) was shown at CinemaCon in Las Vegas on Monday. Despite the fact that Venom is still one of the most anticipated films of the year, there was no sign of Carnage.
According to multiple inside sources, Sony is planning to postpone the release of Venom: Let There Be Carnage until January 21, 2022 — the same date as the Jared Leto vampire-superhero thriller Morbius — but the studio is holding off until after CinemaCon, the annual extravaganza where movie-theater executives and owners come to be dazzled by the latest releases.
Why Venom: Let There Be Carnage Got Delayed?
The short-term outlook, according to studio sources reached by Vulture, is that autumn’s big films (like Dune and Top Gun: Maverick) will most likely keep their scheduled release dates — though Marvel Studio’s Eternals could be delayed if the 24th.
The movie industry is still a hits-driven business, even in an era of growing streaming domination. Despite reports that North American box office sales will drop by 80% in 2020, reaching a 40-year low due to the coronavirus outbreak, neither Sony nor MGM had ever contemplated selling Venom or No Time to Die to deep-pocketed OTT platforms like Netflix or Apple+.
Eon is crossing its fingers that audiences’ comfort levels rise over 81 percent again for Bond, and is “hoping for the $700, $800 [million] range,” according to a source close to the business. “There’s no chance they’ll make it there.” But there’s a chance there’ll be some cover: ‘We weren’t planning on doing a large amount.’ We can point the finger at COVID, conduct some business in the United States, and move on.’”